
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
Counterfeiting Hits Top & Bottom Lines Amid Increased Price Pressure
February 27th, 2019
Face2Face with MeiLin Wan
February 21st, 2019
New Licensing Deal Adds Fresh Buzz To Joint Venture
February 14th, 2019
Applied DNA Reports FY’19 Q1 Results
February 7th, 2019
Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)
February 6th, 2019
“From Dirt to Shirt”: Traceability Solutions for Textiles
February 6th, 2019
Globetrotting Applied DNA Has It Made In Taiwan
February 5th, 2019
Applied DNA partners with Taiwanese Tex-Ray
January 30th, 2019